A polymer, its preparation method and its application in chemiluminescent reagents

The polymer PDX-HES-IPM, prepared by modifying polydextrose, hydroxyethyl starch and isopropyl myristate, solves the problem of poor compatibility of polymer materials in in vitro diagnostic reagents, realizes domestic production and improves detection performance, and is suitable for chemiluminescence reagents and magnetic particle detection.

CN123107094APending Publication Date: 2026-11-17J&W BEIJING BIOTECH CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202611485086.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2026-09-22
Publication Date
2026-11-17

AI Technical Summary

Technical Problem

Existing polymer materials used in in vitro diagnostic reagents suffer from limitations such as single function, poor water solubility of hydrocolloids, and insufficient compatibility with bioactive components in terms of density, kinematic viscosity, zeta potential, and osmotic pressure. These issues lead to inaccurate test results, high false positive rates, severe non-specific adsorption, and reliance on unstable supply of imported raw materials, making domestic production difficult.

Method used

A modified polymer, PDX-HES-IPM, prepared using modified polydextrose (PDX), hydroxyethyl starch (HES), and isopropyl myristate (IPM), forms a copolymer network structure through etherification crosslinking and ethylene oxide chain extension. Characterized by FT-IR, UV-Vis, and ESI-MS, it is used to prepare magnetic nanospheres and chemiluminescence reagents, thus optimizing the composition of a magnetic microparticle chemiluminescence detection kit.

Benefits of technology

It significantly inhibits nonspecific adsorption, improves signal-to-noise ratio and detection precision, reduces coefficient of variation, enhances the storage stability and detection sensitivity of the kit, reduces the risk of missed detection in clinical settings, and enables domestic production and cost control.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure FT_1
    Figure FT_1
  • Figure FT_2
    Figure FT_2
  • Figure FT_3
    Figure FT_3
Patent Text Reader

Abstract

This invention provides a polymer, its preparation method, and its application in chemiluminescence reagents. The polymer is a modified PDX-HES-IPM, prepared by chain extension modification of modified PDX, HES, and IPM with ethylene oxide. It is a complex that combines the hydrophilic stability of PDX, the steric hindrance between HES segments, and the hydrophobic ester groups of IPM. This complex can be used as a dispersant to expand the volume of nanomagnetic microspheres with multilayered carboxyl functional groups and strong magnetic properties. It can also be added as an excipient functional agent to reagents R1, R2, and M in chemiluminescence reagent kits, and can be used in upstream coating buffer solutions. Adding it at a ratio of 0.01% to 5% can significantly suppress nonspecific adsorption, reduce background signal, improve signal-to-noise ratio, eliminate magnetic bead floating phenomenon, reduce blank value and coefficient of variation, and improve thermal stability without affecting reagent linearity and precision. This is beneficial for significantly reducing the risk of false negatives in clinical detection of low-value samples and is widely applicable to various magnetic microparticle chemiluminescence detection scenarios.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to the fields of biochemistry and in vitro diagnostic reagents, specifically to a hydrophilic and hydrophobic amphiphilic polymer, and to a method for preparing the polymer and its various applications in chemiluminescent reagents. Background Technology

[0002] The core performance indicators of in vitro diagnostic (IVD) reagents (such as stability, sensitivity, and specificity) directly determine the accuracy and repeatability of test results. Therefore, the requirements for the components of various chemical reagents in the formulation are extremely high. Traditional formulations rely heavily on polymers such as PEO / PEG, polyglycerol (PG), polylysine (PLL), Ficoll, and isopropyl myristate (IPM). However, single-component polymers have limited functions, and some hydrocolloids have poor water solubility, density, kinematic viscosity, zeta potential, osmotic pressure, and incompatibility with bioactive components, which can easily cause turbidity and stratification of the system. For example, they can interfere with the optical signal reading of chemiluminescent reagents. These technical defects and industry pain points have gradually become prominent, becoming key bottlenecks restricting the high-quality development of domestic IVD reagents.

[0003] Interference and incompatibility can lead to unreliable diagnostic results. For example, the positive detection rate of anti-PEG antibodies in the population can be as high as 30%-70%. These antibodies can specifically bind to PEG / PEO in reagents, inducing immune cross-reactions, directly causing false positives, numerical drift, decreased precision, and substandard sample recovery rates. This is particularly evident in the detection of tumor markers and autoimmune diseases, seriously threatening the reliability of diagnostic results. In addition, existing polymer materials have poor compatibility with complex clinical samples (such as high-fat, high-turbidity samples or samples containing rheumatoid factor), easily causing non-specific adsorption and leading to inconsistencies between serum and plasma test results, increasing the risk of clinical misjudgment due to unreliable diagnostic results.

[0004] Technological bottlenecks in domestic substitution. The long-term reliance on imported core polymer raw materials and insufficient supply chain stability severely restrict the large-scale production and cost control of domestic IVD reagents. Attempts have been made to use simple alternatives such as mannitol, dextran, or polyol blends, but these suffer from fundamental defects such as insufficient hydroxyl density, weak steric retardation, and poor anti-adsorption effects, failing to replace traditional PEG-based materials. Meanwhile, domestically produced alternative polymers exhibit quality defects such as wide degree of polymerization distribution, high residual monomer content, and numerous impurities, directly reducing reagent detection performance. Successful domestic substitution requires large-scale adjustments to formulation ratios, buffer systems, and production processes, significantly increasing R&D costs and the risks of mass production.

[0005] Patent barriers. Leading international companies have built robust patent barriers around materials such as PEG / PEO, dextran microspheres, and polyglycerol esters with different molecular weights and end-group modifications, focusing on specific application concentrations and compatibility systems in the IVD field. This makes it extremely easy for domestic companies to face compliance production risks due to infringement when using their related solutions.

[0006] Given the multiple challenges faced by polymer materials, including industry pain points, clinical interference, performance defects, supply bottlenecks, and patent barriers, the IVD industry urgently needs to develop a domestically produced polymer material with a novel molecular structure and performance (water solubility, compatibility, etc.) that matches or even surpasses imported products. This material should possess excellent stability, biocompatibility, anti-adsorption properties, and seamless integration with existing production processes. It should be easy to achieve domestic, large-scale, and compliant production with stable and controllable quality, thereby promoting the formulation upgrade, cost reduction, and efficiency improvement of core raw materials for IVD products. Summary of the Invention

[0007] The purpose of this invention is to overcome the technical defects of existing polymers and provide a polymer suitable for the core components of infectious disease reagents, which can replace traditional materials such as polyoxyethylene (PEO / PEG), polyglycerol (PG), polylysine (PLL), polysucrose (Ficoll), and polyIPM.

[0008] The present invention also aims to provide a polymer prepared by modification of polydextrose (PDX), hydroxyethyl starch (HES) and isopropyl myristate (IPM).

[0009] Another objective of this invention is to provide a polymer that can improve the performance and address the technical problems of existing chemiluminescent reagents.

[0010] To achieve the above-mentioned objectives, the present invention is implemented through the following technical solutions.

[0011] In a first aspect, the present invention provides a polymer-modified PDX-HES-IPM, which is a composite with a copolymer network structure prepared from modified polydextrose, hydroxyethyl starch and isopropyl myristate as raw materials.

[0012] According to a preferred embodiment of the present invention, the polymer-modified PDX-HES-IPM incorporates hydrophobic ester groups of isopropyl myristate segments through the expansion linking of a polyethylene glycol structure formed by ring-opening of ethylene oxide.

[0013] According to a preferred embodiment of the present invention, the polymer-modified PDX-HES-IPM comprises a polysaccharide backbone formed by modified polydextrose and hydroxyethyl starch with hydrophilic stability, and hydrophobic IPM ester functional groups.

[0014] According to a preferred embodiment of the present invention, the polymer-modified PDX-HES-IPM, as demonstrated by FT-IR, UV-Vis and ESI-MS chemical structural characterization, possesses the characteristic functional groups of the three raw materials: modified PDX, HES and IPM.

[0015] According to a preferred embodiment of the present invention, the polymer-modified PDX-HES-IPM, as demonstrated by ESI-MS chemical structure characterization, has a characteristic ion signal at 293.25 m / z.

[0016] In a second aspect, the present invention provides a method for preparing the polymer-modified PDX-HES-IPM described in the first aspect, comprising the following steps: 1) In the presence of propylene glycol and an alkaline catalyst, modified polydextrose and hydroxyethyl starch undergo an etherification crosslinking reaction under heating conditions to obtain a modified PDX-HES with a copolymer network structure; 2) Isopropyl myristate is completely dissolved in a solvent and transferred to the modified PDX-HES obtained in step 1), and isopropyl myristate is introduced into the polymer backbone by adding ethylene oxide polyethylene glycol under inert gas protection and heating conditions to obtain a ternary polymer backbone modified PDX-HES-IPM; 3) The backbone modified PDX-HES-IPM obtained in step 2) is neutralized with acetic acid, purified, dehydrated and dried to obtain the target polymer-modified PDX-HES-IPM.

[0017] According to a preferred embodiment of the present invention, the mass ratio of the modified polydextrose, hydroxyethyl starch, and isopropyl myristate is 10:10:1. According to a preferred embodiment of the present invention, in step 1), propylene glycol is used as the reaction medium and KOH solution is used as the alkaline catalyst.

[0018] According to a preferred embodiment of the present invention, in step 1), the etherification crosslinking reaction is carried out under an oil bath at 125 °C for 4 h.

[0019] According to a preferred embodiment of the present invention, in step 2), the solvent is ethanol.

[0020] According to a preferred embodiment of the present invention, in step 2), the modified PDX-HES obtained in step 1) needs to be continuously stirred and reacted at 150 °C in an oil bath for 9 h to fully activate the IPM.

[0021] According to a preferred embodiment of the present invention, in step 2), the inert gas is nitrogen.

[0022] According to a preferred embodiment of the present invention, in step 2), the addition of ethylene oxide to ethylene glycol for expansion and polymerization of isopropyl myristate requires a further polymerization reaction at 150 °C in an oil bath for 5 h.

[0023] According to a preferred embodiment of the present invention, in step 3), the pH value of the acetic acid neutralization system is pH 6.8~7.2.

[0024] According to a preferred embodiment of the present invention, in step 3), the purification method can be either rotary evaporation under reduced pressure or column chromatography separation.

[0025] According to a preferred embodiment of the present invention, in step 3), the dehydration drying conditions are vacuum dehydration drying at 120 °C for 30 min.

[0026] Thirdly, the present invention provides a magnetic nanosphere prepared by using the polymer-modified PDX-HES-IPM described in the first aspect, wherein the surface of the magnetic nanosphere is coated with multiple carboxyl functional groups and / or embedded with more Fe3O4 nanoparticles.

[0027] According to a preferred embodiment of the present invention, the magnetic nanospheres are prepared by a two-step preparation process.

[0028] Preferably, the first step in the preparation process of the nanomagnetic microspheres is to prepare the basic core of the carboxyl magnetic microspheres.

[0029] Preferably, the second step in the preparation process of the nanomagnetic microspheres is to coat the surface of the microspheres with a multilayer carboxyl group outer functional shell.

[0030] More preferably, the second step of the nanomagnetic microsphere preparation process includes two preparation methods: the nanomagnetic microspheres prepared by method 1 are multilayer carboxyl-based strongly magnetic microspheres, and the nanomagnetic microspheres prepared by method 2 are hydrophilically modified multilayer magnetic microspheres with high carboxyl density.

[0031] Fourthly, the present invention provides a magnetic microparticle chemiluminescence detection kit, the kit comprising reagent R1, reagent R2 and reagent M, wherein at least one reagent contains the polymer-modified PDX-HES-IPM described in the first aspect.

[0032] According to a preferred embodiment of the present invention, in the magnetic microparticle chemiluminescence detection kit, the mass concentration of polymer-modified PDX-HES-IPM added is 0.01% to 5%.

[0033] According to a preferred embodiment of the present invention, in the magnetic microparticle chemiluminescence detection kit, the M reagent is a magnetic microsphere suspension coated with specific antibodies and / or antigens, and the coating buffer in the preparation process of the magnetic microsphere suspension contains the polymer-modified PDX-HES-IPM described in the first aspect.

[0034] Preferably, reagent R1 can be combined with reagent M to form a magnetic bead working solution, that is, simultaneously containing added polymer-modified PDX-HES-IPM and a magnetic microsphere suspension coated with specific antibodies and / or antigens.

[0035] Fifthly, the present invention provides the application of the polymer-modified PDX-HES-IPM described in the first aspect, the preparation method of the polymer-modified PDX-HES-IPM described in the second aspect, the magnetic nanospheres described in the third aspect, and the magnetic microparticle chemiluminescence detection kit described in the fourth aspect in the preparation of in vitro diagnostic reagents, wherein the application does not include methods for the diagnosis and treatment of diseases.

[0036] The beneficial effects of this invention are: This invention provides a polymer, its preparation method, and its application in chemiluminescent reagents. The polymer provided by this invention is a modified PDX-HES-IPM prepared by modifying polydextrose (PDX), hydroxyethyl starch (HES), and isopropyl myristate (IPM). The modified PDX-HES-IPM is demonstrated by FT-IR, UV-Vis, and ESI-MS to be a complex that combines the hydrophilic stability of the PDX polysaccharide backbone, the steric hindrance protection of the HES chain segment, and the hydrophobic ester functional groups on the IPM. Modified PDX-HES-IPM can be used as a dispersant for the expansion preparation of nanomagnetic microspheres with multilayered carboxyl functional groups and strong magnetic properties. It can also be added as an exogenous functional agent to reagents R1, R2, and M in magnetic microparticle chemiluminescence kits. Furthermore, it can be applied to upstream key preparation solutions such as coating buffer solutions. Results show that adding 0.01%-5% modified PDX-HES-IPM can significantly suppress non-specific adsorption during chemiluminescence detection and construct [a process] on the surface of magnetic beads. The stable hydration steric hindrance layer significantly reduces reagent background signal and improves the signal-to-noise ratio (P / N value) of the kit. Its addition to the upstream coating buffer solution can also eliminate the floating wall phenomenon during the magnetic microsphere coating process, thereby further reducing the blank value and coefficient of variation (CV≤8%) of chemiluminescence detection, improving the storage stability of the kit (signal retention rate >95% after 14 days at 37℃), and does not affect the linearity and precision of the kit. This is beneficial for significantly reducing the risk of false negatives in clinical detection of low-value samples and is widely applicable to various magnetic microparticle chemiluminescence detection scenarios.

[0037] The modified PDX-HES-IPM polymer provided by this invention is a ternary copolymer constructed through a chemical modification strategy. It is a polymer with a cross-linked network structure composed of a polysaccharide backbone (modified PDX-HES). Its preparation process is simple, it has good biocompatibility, does not contain organic toxic components, has no interfacial interference, no aggregation, no precipitation, no background interference, and has good compatibility with different in vitro diagnostic reagent systems. The design and preparation of this polymer is based on the following approach: Modified polydextrose (PDX) and hydroxyethyl starch (HES) provide a highly branched hydrophilic polysaccharide backbone. Modified PDX imparts excellent water solubility and numerous hydrogen bonding sites to the polysaccharide backbone, while HES provides a linear long-chain structure, enhancing the steric hindrance and cross-linking stability of the polysaccharide backbone. Isopropyl myristate (IPM) is introduced into the complex via PEGylation of polyethylene glycol (PEG) segments formed through ethylene oxide ring-opening, thus endowing the ternary polymer with hydrophobic ester functional groups. Therefore, the modified PDX-HES-IPM retains the high hydrophilic stability of modified polydextrose, relies on the hydroxyethyl starch segments for sufficient steric hindrance protection, and introduces the hydrophobic ester functional groups of isopropyl myristate, forming a unique molecular structure with both hydrophilic and hydrophobic amphiphilic side chains. The polymer was systematically validated using three chemical structural characterization methods: FT-IR, UV-Vis, and ESI-MS. This confirmed that the modified PDX-HES-IPM had no free small molecule residues, excellent biocompatibility, and did not exhibit non-specific binding with antibodies, antigens, or other biological ligands in the reagents. It is a ternary copolymer complex structure possessing the characteristic signals of its raw material components: modified PDX, HES, and IPM. The functional segments of the three raw materials are organically integrated into the molecular backbone of the same polymer through chemical bonds, giving it the hydrophilic stability of a polysaccharide backbone, the steric protection of HES, and the hydrophobicity of IPM ester groups. This forms an amphiphilic polymer with interfacial affinity and multifunctional synergy. The unique structure of this polymer-modified PDX-HES-IPM solves the technical defects of traditional single-component additives (such as PEG, dextran, mannitol, etc.) at the molecular level, including single function, poor compatibility, and immunogenicity risks. This provides a safe and reliable research foundation at the molecular level for personalized performance optimization in subsequent specific application scenarios. Furthermore, the raw materials for preparing the polymer-modified PDX-HES-IPM of this invention—modified polydextrose (PDX), hydroxyethyl starch (HES), and isopropyl myristate (IPM)—are all domestically produced and can be mass-produced and applied in industrial settings. The raw materials have stable purity and a continuous supply, eliminating dependence on imported raw materials and helping to further reduce the production cost of polymers.

[0038] Regarding the application of the polymer of this invention in the expansion and preparation of magnetic microspheres, the preparation of magnetic microspheres with multi-layered carboxyl groups (hereinafter referred to as magnetic beads) adopts a two-step preparation process: first, the basic core of the magnetic microsphere is prepared, and then the outer carboxyl functional coating is applied. In the first step, during the "growth" of styrene polymer network microspheres formed by the copolymerization and crosslinking of St and MAA, the Fe3O4 nanoparticles in the microfluidic are not chemically bonded to the polymer, but are physically and randomly trapped inside and on the surface of the polymer network microspheres. This magnetization process is simpler and more direct. The second step sets up two differentiated preparation methods: Method 1 adds magnetic fluid in the coating stage, which can directionally prepare multi-layered magnetically loaded high magnetic response microspheres, greatly improving the magnetic separation speed and adapting to high-throughput automated chemiluminescence detection scenarios; Method 2 only adds styrene and MAA monomers for copolymerization, which can be customized to obtain superhydrophilic low-adsorption microspheres with high carboxyl density, adapting to the stringent requirements of low-background infectious disease biomarker detection. The two types of microspheres produced by the two pathways in step two can be adapted to different detection needs, covering the differentiated needs of different IVD detection scenarios. The key to preparing the microspheres lies in introducing the polymer (modified PDX-HES-IPM) of this invention as a functional additive in each of the two-step preparation process. This hydrophilic modified polymer is directly embedded into the outer polymeric framework of the microspheres. This not only achieves precise and controllable adjustment of hydrophilicity and hydrophobicity but also facilitates the synergistic and stable existence of Fe3O4 nanoparticles at the oil / water interface of the microspheres through steric hindrance or hydrophobic interactions, promoting their encapsulation and providing more stable superparamagnetic properties. The two-step preparation process of this invention can achieve multilayer expansion growth of carboxyl sites without additional intermediate purification steps, constructing a high-density carboxyl distribution system on the surface of the microspheres.

[0039] Furthermore, when polymer-modified PDX-HES-IPM is used as a dispersant for the expansion preparation of magnetic microspheres, the modified PDX-HES-IPM is deeply involved in every step of the magnetic microsphere preparation process, promoting the coating of multiple carboxyl functional groups on the surface of the magnetic microspheres. The cross-linked network structure of the modified PDX-HES-IPM not only endows the nanomagnetic microspheres with more saturated and strong magnetism by embedding more Fe3O4 nanoparticles, which is beneficial to improving the magnetic separation rate, but the polysaccharide skeleton can also effectively inhibit the aggregation of Fe3O4 nanoparticles through steric hindrance effect. The long-chain structure of the S-segment can form a hydration layer on the surface of the microspheres, reducing van der Waals forces between particles. The PEGylated IPM segment, through its amphiphilic regulatory effect, optimizes the distribution behavior of the microspheres at the interface between the aqueous and oil phases. The synergistic effect of these three components ensures that the microspheres remain monodisperse during polymerization and growth, making them less prone to adhesion to the reactor walls and agglomeration. This effectively avoids adhesion to the reactor walls and particle aggregation, ensuring that the magnetic fluid maintains a stable dispersion during polymerization. It also significantly improves the particle size uniformity and colloidal stability of the magnetic microspheres, ultimately yielding high-quality magnetic microspheres with uniform particle size (2.15 μm), controllable magnetic content (two differentiated preparation methods), a CV value (less than 1%) far lower than conventional processes, and high carboxyl density (multi-layer coating). This solves the industry pain point of large performance fluctuations in the mass production of magnetic microspheres. At the same time, the presence of a large number of hydroxyl and carboxyl functional groups in the polymer molecule provides sufficient active sites for further biofunctionalization of the magnetic microsphere surface, which is beneficial for the efficient coating and conjugation of antibodies or antigens.

[0040] Polymer-modified PDX-HES-IPM, as an excipient functional additive, can be added to reagents R1, R2, and M of magnetic microparticle chemiluminescence reagents. Specific experimental verification has shown that modified PDX-HES-IPM can be added in parallel at concentrations of 0.01% to 5% to reagents R1 (reaction buffer), R2 (luminescent label conjugate, such as reagents containing acridinium ester or alkaline phosphatase-labeled monoclonal antibodies), and M (reagents containing magnetic microspheres coated with specific antigens / antibodies) of magnetic microparticle chemiluminescence kits, where it exerts a targeted functional optimization effect in each reagent. In reagent R1, the polymer forms an ultrathin hydration layer in the liquid-phase reaction system through a hydrophilic backbone and PEG segments, protecting the microenvironment and reducing non-specific adsorption of bioactive components (such as antigens and antibodies) during the reaction. In reagent R2, the polymer of this invention protects the labeled protein through steric hindrance, preventing its aggregation and activity reduction, while also reducing non-specific adsorption of luminescent labels to non-targets. In reagent M, the polymer forms a hydrophilic modification layer on the surface of magnetic microspheres (or magnetic beads), effectively inhibiting aggregation between magnetic beads and non-specific protein adsorption. When modified PDX-HES-IPM is added to each of the three reagents, the polymer has been experimentally verified in each component to increase the detection signal-to-noise ratio (P / N value) by 7%-72% without affecting the antigen-antibody immunobinding activity. The synergistic effect of adding the three reagents simultaneously can control the blank value coefficient of variation (CV) to within 8%, significantly improving the sensitivity and precision of the detection system.

[0041] Polymer-modified PDX-HES-IPM can be directly applied to key upstream preparation solutions (such as magnetic microsphere-coated buffer solutions), optimizing the coupling environment of magnetic microspheres (magnetic beads) from the source of the process. The application method involves adding modified PDX-HES-IPM to the magnetic microsphere coating buffer (CB) during the magnetic microsphere coating process. Introducing this polymer during the magnetic microsphere coating stage allows it to participate in the construction of the specific antigen / antibody interface for solid-phase magnetic microsphere coating. This facilitates more uniform and ordered directional coupling of antibodies or antigens in the coating buffer on the magnetic bead surface. Simultaneously, the polymer chains form a stable hydration steric hindrance layer on the magnetic bead surface, resulting in multiple benefits: First, it significantly reduces non-specific adsorption of the magnetic microspheres during coating, eliminating the floating and adhering phenomena that often occur with traditional single-component surfactants, improving the suspension stability and dispersion uniformity of the magnetic beads during storage and use. Second, because the coated magnetic beads have a pre-constructed anti-adsorption layer on their surface, they exhibit lower background and higher signal-to-noise ratio after subsequent assembly into a complete kit. Third, because the polymer binds tightly to the magnetic bead surface during the coating stage, its protective effect is more durable and contributes more significantly to the long-term stability of the kit. Experiments have confirmed that this addition scheme significantly reduces blank values, with a coefficient of variation (CV) ≤ 8%. After 14 days of accelerated processing at 37°C, the signal retention rate is > 95%, exhibiting higher stability. The signal enhancement factor represented by ΔP / N ranges from 13% to 101%, which is beneficial for significantly improving the distinction between the luminescent signal and negative background of low-value borderline positive samples. Furthermore, it is anticipated that the polymer-modified PDX-HES-IPM of this invention can not only be directly added to magnetic microsphere-coated buffer solutions but also has the potential to be extended to upstream reagents or solutions such as sample diluents, antigen / antibody pretreatment solutions, solubilizers, surfactants, and anti-interference agents.

[0042] The improvement of the overall performance of the magnetic particle chemiluminescence detection kit by adding modified PDX-HES-IPM in the above three dimensions is reflected in the following aspects: the blank value is significantly reduced and the signal-to-noise ratio (P / N) is greatly improved; the precision (CV≤8%) and thermal stability (signal retention rate >95% after 14 days at 37℃) both reach the ideal kit quality standards; the linear range (0.1~160 ng / mL) is well maintained without introducing new concentration-dependent interference; the detection capability of low-value samples is significantly enhanced, effectively reducing the risk of clinical missed detection or misjudgment of borderline samples. It is evident that the mechanism of action of the polymer of this invention does not depend on a specific detection target, but rather reduces non-specific adsorption by forming a hydration interface on the surface of magnetic microspheres, in the liquid-phase reaction system, and in core reagents such as chemical markers, thus exhibiting good versatility. Experiments have demonstrated that the application of the polymer of this invention is not limited to the detection of hepatitis C virus (HCV) antibodies, human immunodeficiency virus (HIV) antigens and antibodies, and heart-shaped fatty acid-binding protein (H-FABP) as verified in this invention. It is reasonable to speculate that it can also be widely extended to the detection of other magnetic microparticle chemiluminescence markers, such as tumor markers, myocardial markers, autoimmune disease antibodies, and infectious disease pathogen antigens / antibodies, and even to other IVD-related reagent detection fields such as colloidal gold, biochemical reagents, immunoassay systems (such as ELISA, immunochromatography, etc.), and molecular diagnostic sample preservation solutions, demonstrating good technology transferability, strong industry adaptability, and broad prospects for industrialization and application. Attached Figure Description

[0043] Figure 1 FI-IR spectra of magnetic microspheres prepared using the polymer of this invention.

[0044] Figure 2 UV-Vis spectra of magnetic microspheres prepared using the polymer of this invention.

[0045] Figure 3 ESI-MS spectra of magnetic microspheres prepared using the polymer of this invention.

[0046] Figure 4 The image shows the morphology of magnetic microspheres (without particle size screening) prepared using the polymer of this invention under an optical microscope.

[0047] Figure 5 The image shows the particle size of magnetic microspheres (without particle size screening) prepared using the polymer of this invention, as measured by a particle size analyzer. In this image, 1 represents the second step of the two-step preparation process using method 1, and 2 represents the second step of the two-step preparation process using method 2. Detailed Implementation

[0048] The exemplary embodiments of the present invention are described in detail below with reference to the accompanying drawings, wherein the same or similar expressions include the same concepts, such as polydextrose = PDX, hydroxyethyl starch = HES, isopropyl myristate = IPM, polymer = modified polydextrose-hydroxyethyl starch-isopropyl myristate = modified PDX-HES-IPM, magnetic microspheres = magnetic beads = magnetic microparticles; in the following detailed description, many specific details are set forth to provide a full understanding of the embodiments disclosed herein for ease of explanation. The following embodiments are for illustrative purposes only and should not be regarded as limiting the scope of the present invention.

[0049] Unless otherwise specified, the experimental methods used in the following examples are conventional methods, and the materials and reagents used are commercially available. Modified polydextrose (PDX), hydroxyethyl starch (HES), and isopropyl myristate (IPM, high purity ≥99%) were purchased from Sinopharm, Xibao, and other raw material companies. Salts, proteins, and other commonly used reagents were purchased from Sigma, Xibao, Sinopharm, and other companies. The fully automated chemiluminescence analyzer Wan200+ was from Xiamen Youmaike Medical Instruments Co., Ltd. The relevant in vitro diagnostic reagents based on chemiluminescence were kits registered and publicly sold by Xiamen Wantai Kairui Biotechnology Co., Ltd. (Hepatitis C Virus Antibody Detection Kit (Magnetic Particle Chemiluminescence Method) (National Medical Device Registration Certificate 20163401239), Human Immunodeficiency Virus Antigen Antibody Detection Kit (Magnetic Particle Chemiluminescence Method) (National Medical Device Registration Certificate 20163401355), and Heart-shaped Fatty Acid Binding Protein Assay Kit (Magnetic Particle Chemiluminescence Method) (Fujian Medical Device Registration Certificate 20212400247)). However, it is obvious that one or more embodiments may be implemented without these specific details, and where no specific conditions are specified in the embodiments, they shall be performed in accordance with conventional conditions or conditions recommended by the manufacturer or product instructions.

[0050] This invention provides a novel polymer—modified polydextrose-hydroxyethyl starch-isopropyl myristate polymer (modified PDX-HES-IPM). This polymer (modified PDX-HES-IPM) is prepared by chain extension modification of modified PDX, HES, and IPM with ethylene oxide. It is a composite that combines the hydrophilic stability of PDX, the steric hindrance between HES segments, and the hydrophobic ester groups of IPM. The polymer provided by this invention, its preparation method, and its application in chemiluminescent reagents are detailed below.

[0051] Example 1: Synthesis and Preparation of Polymers This invention uses modified polydextrose (PDX), hydroxyethyl starch (HES), and isopropyl myristate (IPM) as core raw materials to synthesize a new polymer called modified polydextrose-hydroxyethyl starch-isopropyl myristate polymer, abbreviated as modified PDX-HES-IPM. The preparation process of this polymer (laboratory stage) is as follows.

[0052] 1) 5 g each of modified polydextrose (PDX) and hydroxyethyl starch (HES) (both 0.5% by mass) were completely dissolved in pure water. 5 mL of propylene glycol was added as the reaction medium, and 1 mL of KOH solution was added as the alkaline catalyst. During the process of keeping the mixture at 125 ℃ in an oil bath for 4 h, the hydroxyl groups on the molecular chains of PDX and HES underwent an etherification crosslinking reaction to form a stable intermediate product with a copolymer network structure (modified PDX-HES).

[0053] 2) 0.5 g of isopropyl myristate (IPM) (0.05% by mass) was completely dissolved in 20 mL of ethanol and transferred to the above reaction system containing the intermediate product (modified PDX-HES). The temperature was raised to 150 °C and stirred continuously for 9 h under oil bath conditions at 150 °C to fully activate IPM. Subsequently, under the protection of nitrogen gas to isolate oxygen, about 0.5 g of ethylene oxide (EO) was slowly added dropwise to the system, and the polymerization reaction was continued at high temperature for 5 h to achieve polyethylene glycol chain extension modification of IPM segments, thus completing the construction of the ternary polymer backbone (modified PDX-HES-IPM).

[0054] 3) Neutralization and purification: Acetic acid is added to the above reaction system to neutralize the pH to 6.8-7.2. Residual impurities (K) are removed by purification methods such as rotary evaporation under reduced pressure or column chromatography. + The product (including EO, IPM) and byproducts (low molecular weight polyethylene glycol) were dried under vacuum at 120 °C for 30 min. The target product obtained was the ternary copolymer polymer modified PDX-HES-IPM.

[0055] The core raw materials for the above preparation process are modified polydextrose (PDX), hydroxyethyl starch (HES), and isopropyl myristate (IPM), which constitute the key structural components of the main chain. Among them, modified polydextrose (PDX) is a water-soluble polysaccharide polymer with hydroxyl groups in its molecular chain, which can provide a large number of hydrogen bonding sites, helping to improve the hydrophilicity and biocompatibility of the polymer. The treatment of modified PDX can optimize its molecular weight distribution and improve batch-to-batch consistency. Hydroxyethyl starch (HES) is a semi-synthetic polymer modified by hydroxyethylation of natural starch. It has good water solubility and biocompatibility. The natural polymer chain of HES can form a spatial network structure, which enhances the colloidal stability of the system and endows the polymer system with excellent thickening, stabilizing and anti-agglomeration properties. Isopropyl myristate (IPM) is a low-polarity ester molecule that can be used as a hydrophobicity regulator. Its long-chain alkyl structure can endow the polymer with a certain degree of amphiphilicity, which is beneficial to improve the spreading and adsorption behavior of the polymer on complex interfaces. After chain extension with ethylene oxide, the IPM chain segment can achieve fine control of hydrophilic and hydrophobic balance.

[0056] The mass ratio of modified PDX, HES, and IPM is 10:10:1. PDX and HES, as the backbone of the polysaccharide, provide a large number of hydroxyl reaction sites, maximizing the high water solubility, biocompatibility, and hydration layer stability of the target product. The low proportion of IPM, as a hydrophobic modification unit, precisely controls the hydrophilic-hydrophobic balance of the target product, ensuring that the product's water solubility is not reduced due to excessive hydrophobic units, while also endowing the polymer with excellent steric hindrance ability, significantly reducing non-specific adsorption in IVD reagents and meeting the core detection requirements of low background. In addition, PDX and HES are both bulk industrial raw materials with low cost and stable supply; IPM is a commonly used excipient in cosmetics / pharmaceuticals, with a relatively high unit price but a low usage proportion. The 10:10:1 ratio of PDX, HES, and IPM can control the raw material cost to the maximum extent while ensuring functional requirements, which is conducive to subsequent large-scale production and application promotion.

[0057] The auxiliary components in the above preparation process are: propylene glycol, which serves as a reaction medium, improves the solubility and dispersion of PDX and HES in the aqueous phase, enhances the miscibility between PDX and HES components, and its hydroxyl groups may participate in the construction of the hydrogen bond network in the system. KOH, as an alkaline catalyst, lowers the activation energy of the polymerization reaction while activating the hydroxyl groups on the polysaccharide molecular chains to promote the etherification and crosslinking reaction between PDX and HES molecules, forming a stable copolymer network structure. The polyethylene glycol (PEG) chain formed after the ring-opening polymerization of ethylene oxide (EO) is used to extend the chain on the hydrophobic ester backbone of the IPM chain and insert hydrophilic PEG segments, giving the product better water solubility and resistance to non-specific protein adsorption, which is equivalent to modifying the water-based properties of the polymer to further improve its water solubility and stability.

[0058] The reaction conditions of the above preparation process are as follows: nitrogen protection effectively prevents high-temperature oxidation of the product, and the neutralization and purification steps ensure that the residual amount of impurities and by-products in the product is extremely low. The final polymer (modified PDX-HES-IPM) has a coefficient of variation (CV) of less than 5% both within and between batches during the pilot test, which is much higher than the quality control requirements of IVD reagents for raw materials (CV%≤10%).

[0059] The modified PDX-HES-IPM is a white to pale yellow water-soluble powder with a molecular weight distribution in the range of 10,000 to 7,000,000. It has a water solubility of ≥99% and can form a stable hydration layer in aqueous systems (such as phosphate buffer, Tris-HCl buffer, HEPES buffer, etc.). It also has excellent steric impedance adsorption capabilities.

[0060] Example 2: Performance Verification of Polymers To systematically analyze the assembly method and structural characteristics of the polymer (modified PDX-HES-IPM) prepared according to Example 1, three characterization methods were used: Fourier Transform Infrared Spectroscopy (FT-IR), Ultraviolet-Visible Spectroscopy (UV-Vis), and Electrospray Ionization Mass Spectrometry (ESI-MS). The structure and coordination environment of the modified PDX-HES-IPM were systematically verified and analyzed from three dimensions: functional group characteristics, molecular conjugation environment, and molecular weight and structural unit matching degree. The aim was to deeply explore the comprehensive properties of the polymer.

[0061] FT-IR characterization: FT-IR spectroscopic characterization was performed on the three single-component raw materials (modified PDX, HES, and IPM) and the final synthesized target product (modified PDX-HES-IPM). The FT-IR spectra are shown below. Figure 1 As shown. Comparative analysis of the FT-IR spectra reveals: 1) Complete functional groups: The infrared spectrum of the target product simultaneously retains the characteristic peaks of the hydrophilic framework functional groups of modified PDX and HES polysaccharides (attributed to modified PDX and HES), as well as the characteristic peaks of the hydrophobic ester functional groups of IPM. Furthermore, the characteristic peaks exhibit regular peak position shifts, peak broadening, and intensity changes, directly proving that the target product is not a simple physical mixture system, but rather a composite system in which all three raw material components have been successfully introduced into the final polymer. 2) Characteristic peaks of hydroxyl stretching vibrations (3250-3420 cm⁻¹). -1Compared with the characteristic peaks of the raw materials, the hydroxyl characteristic peak of the target product (modified PDX-HES-IPM) is significantly broadened and undergoes a slight red shift, indicating that a large number of hydrogen bond cross-linking networks have been formed between the polysaccharide molecules of the raw materials and between the polysaccharides and the IPM components. The components form a stable composite cross-linking structure through interaction and cross-linking. 3) Alkyl stretching vibration characteristic peak (2850–2960 cm⁻¹) -1 ): The superposition of the alkyl CH stretching vibration peaks of the target product is complete, and the characteristic peaks of the alkyl group show no obvious peak loss or abnormal breakage, proving that the target product was not broken, damaged, or degraded during the synthesis process, and the main chain skeleton structure is intact and stable. 4) Ester group characteristic peaks: The characteristic peak of the ester carbonyl group (C=O) of IPM is from 1735 cm⁻¹. -1 Shifted to 1732 cm from the target product (modified PDX-HES-IPM). -1 Meanwhile, the absorption intensity of the ester bond COC decreased significantly, indicating that the microenvironment of the ester functional group in the IPM changed in the composite system, forming stable non-covalent intermolecular forces with other components. 5) Characteristic peak of long-chain alkyl groups (720 cm⁻¹) -1 The stable presence of this characteristic peak proves that the hydrophobic long-chain alkyl structure of IPM has been successfully introduced into the composite system.

[0062] FT-IR characterization results show that the target product (modified PDX-HES-IPM) is not a simple physical mixture of the three raw material components, modified PDX, HES, and IPM, but an amphiphilic polymer synergistically constructed through non-covalent interactions such as covalent bonds and intermolecular hydrogen bonds. The characteristic functional groups of the three raw materials are completely preserved, and the regular peak shifts and peak shape changes in the spectrum confirm that the target product has a structurally stable composite network structure.

[0063] UV-Vis characterization: The three single-component raw materials (modified PDX, HES, and IPM) and the final synthesized target product (modified PDX-HES-IPM) were all prepared as neutral aqueous solutions of the same concentration. Using the corresponding solvents as blank baselines for background correction, UV-Vis spectroscopic characterization was performed across the entire wavelength range of 190–800 nm. The UV-Vis spectra are shown below. Figure 2 As shown. Figure 2The UV-Vis spectrum shown indicates that: 1) Enhanced absorption and redshift at 190–200 nm: Compared with the single raw material component, the absorption intensity of the target product in this far-ultraviolet end region is significantly enhanced, and the absorption sideband is accompanied by a slight redshift. This change is due to the formation of a large number of hydrogen bond cross-linking networks between molecules. The hydrogen bond effect reduces the energy level difference of the n→σ* electronic transition of the lone pair electrons of oxygen atoms in the molecule, increases the electronic transition probability, and causes the absorption band to shift to the longer wavelength direction, thus increasing the electronic transition probability. Therefore, the spectral signals of the target product and the single raw material component are clearly distinguishable. 2) 225–235 nm exclusive broad absorption shoulder: In this range, the target product exhibits a broad absorption shoulder not found in either the single raw material component or the physically blended system. This signal is a unique characteristic of polymers, proving that it is an electronic energy level rearrangement caused by the interaction between the hydrophilic polysaccharide backbone and the hydrophobic IPM long chain through non-covalent forces (such as hydrogen bonds and hydrophobic interactions). The unique spectral response is generated by the synergistic change in the local electron cloud conjugation environment. This unique spectral feature further provides direct evidence that the target product is a composite assembly. 3) 250–400 nm baseline stable and without impurities: In the mid-to-long wavelength ultraviolet region, the absorption spectrum baseline of the target product is stable throughout, without obvious impurities or scattering fluctuations. This proves that the composite system of the target product has excellent solubility in the aqueous phase, is completely homogeneously dispersed, has no nano-agglomeration or component analysis, and has no visible particulate scattering. It has good solubility, colloidal stability, and storage stability, and the system is in a thermodynamically stable homogeneous state.

[0064] UV-Vis characterization results show that the modified PDX-HES-IPM is not a simple physical superposition of single-component raw materials, but rather a novel, amphiphilic, homogeneous, and stable composite system of polymers with unique spectral response characteristics, formed through supramolecular interactions and ordered structural assembly driven by non-covalent bonds. This is consistent with the FT-IR characterization results above, further proving that the target product is a successfully constructed assembled composite system.

[0065] ESI-MS characterization: Low-concentration methanol-water mixed solutions were prepared for the three single-component raw materials (modified PDX, HES, and IPM), the final synthesized target product (modified PDX-HES-IPM), and the physically blended control sample. ESI-MS mass spectrometry characterization was performed in full mass-to-charge ratio scanning mode. The ESI-MS mass spectra are shown below. Figure 3 As shown, from Figure 3The ESI-MS mass spectra shown indicate that: 1) the backbone signal region of the polymer (120–350 m / z): the target product exhibits a continuous and smooth Gaussian envelope peak in this region. This signal is the superposition signal of the multi-charged ions of the raw material modified polydextrose (PDX) and hydroxyethyl starch (HES). At the same time, a mass shift (characteristic increments of 58 Da and 44 Da) can be observed between the adjacent ion peaks of the envelope peak of the target product. These correspond to the characteristic ion signals of the modified unit (etherified modified group) of modified polydextrose (PDX) and the hydroxyethyl side chain of hydroxyethyl starch (HES), respectively. This means that the characteristic ion signal of the target product simultaneously covers the characteristic ion signals of the hydrophilic polysaccharide backbone and the hydrophobic IPM, directly proving that the main chain backbone and the modified side chain structure of the raw polysaccharide did not undergo chain breakage and degradation during the synthesis process and were ultimately preserved intact in the target product. 2) Characteristic ion signal region of IPM (293.25 m / z): An independent and high-intensity ion peak was detected in this signal region. This signal cannot be generated by the individual ionization of free IPM molecules. Since the molecular weight of IPM is 270.45 Da, while the theoretical value of the [IPM+Na]⁺ molecule is 293.43 Da, this signal belongs to the ion peak of the sodium-added molecule [IPM+Na]⁺ of IPM, confirming that the IPM component has been successfully introduced into the composite system of the target product. In addition, a shift of the characteristic ion peak corresponding to the molecular weight of IPM can be observed at the baseline of the envelope peak of the target product, further proving that IPM is not simply introduced in the form of physically mixed free small molecules, but rather assembled with the high molecular weight polysaccharide backbone through stable intermolecular interactions to form a stable composite structure.

[0066] ESI-MS characterization results showed that effective intermolecular complexation occurred among modified polydextrose (PDX), hydroxyethyl starch (HES), and isopropyl myristate (IPM), forming an amphiphilic composite polymer with a hydrophilic polysaccharide backbone (PDX-HES) and hydrophobic IPM segments. This amphiphilic property (both hydrophilic and hydrophobic) completely ruled out the possibility that the system was a simple physical blend, providing clear molecular-level evidence that the target product is a successfully prepared polymer composite system.

[0067] The combined results of the above three chemical structure characterization methods—FT-IR, UV-Vis, and ESI-MS—form a complete evidence loop: FT-IR, at the functional group vibration level, detected characteristic functional groups in the target product that simultaneously retain a hydrophilic polysaccharide backbone and hydrophobic IPM ester groups, with regular shifts in the peak positions, proving that the components form a unique cross-linked network structure through stable intermolecular interactions such as hydrogen bonds and van der Waals forces; UV-Vis, at the electronic transition level, detected a unique broad absorption shoulder (225–235 nm) in the target product, not found in single-component or physically blended systems. The target product exhibits excellent aqueous homogeneity and stability, further demonstrating that IPM has been introduced into the composite system through intermolecular forces, and that the target product is a composite system of assembled polymers. Electrospray ionization mass spectrometry (ESI-MS) detected that the target product simultaneously possesses polysaccharide backbone signals, IPM characteristic signals, and assembly-related mass shift characteristic signals at the molecular ion mass level. No independent molecular weight peaks of the raw material components were observed. The molecular weight distribution range of the target product completely matches the theoretically calculated molecular weight of the modified PDX-HES-IPM structural unit, proving that the target product is not a simple physical blend between components, but rather a stable intermolecular composite structure formed at the molecular level. The results of the three types of characterization spectra corroborate each other and the core conclusions are consistent, jointly proving that the present invention has successfully achieved intermolecular composite assembly of modified polydextrose (PDX), hydroxyethyl starch (HES), and isopropyl myristate (IPM). The resulting target product (modified PDX-HES-IPM) forms a high molecular polymer with an effective synthetic path, a clear molecular structure, a homogeneous system, a stable structure, and both hydrophilic and hydrophobic properties through non-covalent intermolecular forces such as hydrogen bonds and van der Waals forces, rather than a simple physical mixture of the raw material components.

[0068] Example 3, Application of Polymer 1: Compressed Preparation of Magnetic Microspheres: This invention uses a polymer (modified PDX-HES-IPM) and a two-step preparation process to prepare magnetic microspheres (or magnetic beads) with multiple carboxyl groups on the surface. In the two-step preparation process, the first step is to prepare the basic core of the carboxyl magnetic microsphere, and the second step is to coat the surface of the microsphere with a multi-layer carboxyl functional outer shell. The specific preparation steps are as follows.

[0069] Fe3O4 magnetic nanoparticles and a magnetic fluid were prepared in advance. The preparation steps were as follows: 1) 12 g of ferrous chloride tetrahydrate (FeCl2∙4H2O) and 16 g of ferric chloride hexahydrate (FeCl3∙6H2O) were accurately weighed according to the iron salt molar ratio of 1:1.2 and completely dissolved in 50 g of deionized water to obtain a clear and transparent iron salt mixed solution; 2) The iron salt mixed solution was transferred to a four-necked flask and placed in an oil bath at room temperature. The mixture was mechanically stirred continuously at 200-300 rpm for 2 hours to ensure uniform mixing; 3) The oil bath temperature was raised to 70℃, and 80 g of concentrated ammonia water (NH3∙6H2O, mass fraction of about 25%-28%) was rapidly added dropwise to the flask. After the addition was completed, the stirring speed was adjusted to 600 rpm and mechanical stirring was continued for 1 hour. h) Completely convert the iron salt into Fe3O4 precursor particles; 4) Raise the oil bath temperature to 85℃ and continue mechanical stirring at 600 rpm for 22 hours to complete the crystallization and ripening reaction. Stop heating after this process, and the synthesis reaction is complete; 5) Purify the reaction product by alternating centrifugation and washing with anhydrous ethanol and deionized water until the supernatant is detected as neutral and free of residual impurities. This process yields Fe3O4 nanoparticles; 6) Redisperse the purified Fe3O4 nanoparticles in anhydrous ethanol and vacuum dry them to obtain high-purity, solid Fe3O4 magnetic nanoparticles; 7) In use, redisperse the vacuum-dried Fe3O4 magnetic nanoparticles (solid powder) in a liquid medium (such as water, ethanol, or a dispersion containing surfactant). Disperse them uniformly by ultrasonic or mechanical stirring to form a stable colloidal dispersion system, i.e., a magnetic fluid. The amount of solid magnetic fluid is adjusted according to the needs of microsphere preparation.

[0070] The first step is to prepare the basic core of carboxyl magnetic microspheres: using styrene (St) and methacrylic acid (MAA) as comonomers, trimethylolpropane (TMP) as crosslinking agent, modified polydextrose-hydroxyethyl starch-polyisopropyl myristate (PDX-HES-IPM) as dispersant, potassium persulfate (KPS) as water-soluble initiator, and magnetic fluid as the magnetic source, carboxyl magnetic microspheres are prepared. The specific raw materials, dosages, and preparation process are as follows: accurately weigh 8g St, 16g MAA, 10g KPS, 4g TMP, 0.1g of modified PDX-HES-IPM prepared according to Example 1, 10ml of 1% sodium dodecyl sulfate (SDS) aqueous solution, and the pre-prepared magnetic fluid (the solid amount of Fe3O4 magnetic nanoparticles is 16g). g), and add them sequentially to the reaction vessel. After each component is added, sonicate for 5 min to ensure full dispersion. The sonication program is set as follows: 10 seconds of operation, 2 seconds of interval, and 40% power. After adjusting the pH to 10-11 with ammonia, place the reaction vessel in a reaction apparatus equipped with both reflux condensation and mechanical stirring. The polymerization reaction is carried out for 18 hours under the conditions of an oil bath temperature of 70 ℃ and a mechanical stirring speed of 600 rpm. After the reaction is completed, a stable emulsion of polystyrene magnetic microspheres with carboxyl functional groups on the surface (referred to as carboxyl magnetic microspheres) is prepared.

[0071] The second step involves magnetic microspheres with multiple carboxyl groups coated on their surface, which includes two preparation methods.

[0072] Method 1 is used to prepare multilayer carboxyl-containing strongly magnetic microspheres: The polystyrene microspheres are dispersed in a mixture containing a magnetic fluid, methacrylic acid (MAA), modified PDX-HES-IPM, and an initiator, initiating a polymerization reaction. Specifically, the raw materials, amounts, and preparation process are as follows: In the polystyrene magnetic microsphere emulsion obtained in the first step, the pre-prepared magnetic fluid (4 g of solid Fe3O4 magnetic nanoparticles), 8 g of MAA, 2 g of KPS, 1 g of TMP, and 0.05 g of the modified PDX-HES-IPM prepared according to Example 1 are added sequentially. After each component is added, ultrasonic treatment is performed for 5 min to ensure sufficient dispersion. The ultrasonic program settings are the same as in the first step. The reaction vessel is placed in a reaction apparatus equipped with both reflux condensation and mechanical stirring. The oil bath temperature is set to 70 °C, and the mechanical stirring speed is set to 600 rpm. The polymerization reaction was carried out at rpm for 18 hours; by continuing to add magnetic fluid, the polymerization reaction of Method 1 can form bilayer or even multilayer strong magnetic microspheres with carboxyl functional groups on the surface of polystyrene microspheres.

[0073] Method 2 is used to prepare hydrophilically modified multilayer magnetic microspheres with high carboxyl density: First, the above-mentioned polystyrene microspheres are immersed in a mixture containing styrene (St), methacrylic acid (MAA), and an initiator. St and MAA are polymerized on the surface of the microspheres under suitable conditions (the same polymerization conditions and time as in Method 1) to form a styrene-methacrylic acid copolymer P(St-MAA) coating shell. Then, it is coupled with the working solution of the polymer (modified PDX-HES-IPM) prepared in this invention. The specific raw materials, dosages, and preparation process are as follows: In the polystyrene magnetic microsphere emulsion obtained in the first step, 2g of St, 4g of MAA, 1g of KPS, 0.5g of TMP, and 0.01g of modified PDX-HES-IPM prepared according to Example 1 are added sequentially. After each component is added, ultrasonic treatment is performed for 5 min to ensure sufficient dispersion. The ultrasonic program settings are the same as in the first step. The reaction vessel is placed in a reaction device equipped with reflux condensation and mechanical stirring. The oil bath temperature is set to 70 ℃ and the mechanical stirring speed is set to 600 rpm. The polymerization reaction was carried out at rpm for 18 hours; the polymerization reaction of method 2 formed a double or even multi-layer magnetic nano-coating layer with high-density carboxyl functional groups on the surface of polystyrene microspheres.

[0074] After the above two-step preparation process, the magnetic microspheres coated with multiple carboxyl groups still need to undergo the following post-processing and characterization verification: 1) Washing and storage: After the polymerization reaction of the above two preparation processes is completed, the magnetic microsphere product is first washed three times with ethanol to remove the unreacted monomers and small molecule byproducts remaining in the system; then washed three times with 0.02 M PBST buffer (pH 7.4), and finally dispersed in 0.02 M PBST buffer (pH 7.4) for storage to replace the organic solvent in the original preparation reaction system.

[0075] 2) Morphological characterization: A small amount of the magnetic microspheres preserved in the above-mentioned PBST buffer was serially diluted with 0.02 M PBST buffer (pH 7.4) and then dropped onto a glass slide. After the liquid had spread and dried naturally, the morphology of the microspheres was observed under an optical microscope (40× objective lens). Figure 4 As shown, the morphologies of the two types of magnetic microspheres prepared by the two methods in the second step showed no significant difference, both as... Figure 4 As shown: The magnetic microspheres prepared by this invention exhibit good monodispersity with no obvious agglomeration or adhesion. The particle size of the two types of magnetic microspheres obtained by the two preparation methods in the second step was measured using a particle size analyzer, and the results are as follows. Figure 5 As shown in Table 1 below, the results indicate that the cumulative average particle sizes of the two types of magnetic microspheres prepared by the two methods are 2082.9 nm and 2225.5 nm, respectively, which are very stable, with an average value of 2154.2 nm (approximately 2.15 μm). The standard deviation (SD) of a single measurement is 100.9 nm, resulting in a coefficient of variation (CV) of only about 4.7% (less than 5%), indicating excellent batch-to-batch repeatability and a very stable preparation process. Although the histogram mean particle sizes are 68016.1 nm and 20781.4 nm, respectively, Figure 5 As shown in Table 1, the main peaks (d50) of the particle size distribution are 1872.3 nm and 1848.6 nm, respectively, which are very stable. The average value is stable at 1860.4 nm (about 1.86 μm). In summary, the average particle size of the magnetic microspheres prepared by the polymer of this invention is stable in the range of 2.0 ± 0.16 μm. The micron-sized particles (particles of ~2 µm and above) settle faster in the subsequent magnetic separation and purification operation. In practical applications, the magnetic microspheres of this micron-sized size can be quickly attracted by the magnet, which significantly shortens the operation time and is beneficial to improving the magnetic separation efficiency.

[0076] Table 1. Particle size detection results of the two types of magnetic microspheres

[0077] 3) Purification and concentration standardization: The magnetic microspheres stored in the above PBST buffer were purified by magnetic separation. 50 μL of the purified magnetic microsphere suspension was accurately measured and dried in a 37℃ oven for 3 h until constant weight. The dry weight was weighed and the magnetic microspheres were adjusted to a mass concentration of 100 mg / mL with 0.02 M PBST buffer (pH 7.4) as the standard storage concentration.

[0078] 4) Performance testing: Take the magnetic microspheres (100 mg / mL) after the above-mentioned volume adjustment, and complete the functional modification of the magnetic microspheres by covalent coating with antibodies (or antigens) to prepare the magnetic separation reagent (M reagent) in the chemiluminescence immunoassay (CLIA) kit. Subsequently, experimental verification was carried out in conjunction with a specific infectious disease chemiluminescence kit detection system to evaluate the functionalization effect and detection performance of the magnetic microspheres, and to confirm whether the magnetic microsphere product prepared by introducing polymers in this invention can meet the specific detection requirements of low background and high sensitivity in IVD detection.

[0079] The above-described two-step preparation process using a modified PDX-HES-IPM polymer to prepare polystyrene magnetic microspheres with expanded carboxyl functional groups results in superior dispersibility of the prepared magnetic microspheres. This is because the modified PDX-HES-IPM polymer is introduced as a dispersant in both steps of the preparation process, resulting in less adhesion to the wall, less aggregation, lower detection background, and less non-specific adsorption.

[0080] In the two-step preparation process described above, the magnetic fluid provides superparamagnetic properties to the final functionalized magnetic microspheres, solving the technical problem of low magnetic content in polystyrene microspheres with a single carboxyl functional group layer. The copolymer coating layer of styrene (St) and methacrylic acid (MAA), with St as the structural monomer, forms a hydrophobic framework for the polystyrene magnetic microspheres during polymerization, providing excellent sphericity and resulting in rounded, uniformly sized magnetic microspheres that are easily controlled precisely by adjusting the polymerization process. Methacrylic acid (MAA), as a comonomer, can adjust the hydrophilicity and flexibility of the polymer chains, optimize the suspension stability of the microspheres in biological buffer solutions, and also enhance the carboxyl content through copolymerization. The covalent introduction of functional groups into the coating layer results in a uniform and dense distribution of functional groups on the microsphere surface, providing abundant active sites for subsequent efficient conjugation of biomolecules such as antibodies and antigens. Modified PDX-HES-IPM not only serves as a dispersant to solve the problem of poor dispersibility in single aqueous or oily systems, but also facilitates the formation of a flexible hydrophilic steric hindrance on the microsphere surface by coating it with an outer shell, allowing for a more uniform distribution of multilayer carboxyl groups to reduce stacking and adhesion. This fundamentally reduces the probability of microspheres sticking to the wall and agglomerating. The addition of modified PDX-HES-IPM also helps to directly block the non-directional adsorption of non-specific proteins through flexible steric hindrance, improving the specific adsorption performance of the prepared multilayer carboxyl microspheres. Furthermore, the multilayer carboxyl microspheres constructed in two steps in this invention have a more uniform and denser distribution of multilayer carboxyl groups on their surface, with a greater and richer amount of functional groups. The carboxyl functional groups mainly originate from the carboxyl groups (−COOH) on the molecular structure of MAA after polymerization. The carboxyl groups on the polysaccharide side chains of the modified PDX-HES-IPM polymer molecular chain also intercalate into the microsphere skeleton during the polymerization reaction, which can additionally supplement a small number of hydrophilic carboxyl sites and optimize the aqueous dispersibility of the microspheres. The high density of multilayer carboxyl functional groups can avoid the appearance of exposed hydrophobic blank areas on the surface of the microspheres and can also further reduce the non-specific adsorption sites of the microspheres.

[0081] Regarding the encapsulation of magnetite (Fe3O4) magnetic nanoparticles, traditional encapsulation methods typically employ a route of "first forming polymer microspheres, then mixing them with magnetic particles." This method is prone to generating a large number of blank microspheres due to the lack of chemical affinity between the magnetic particles and the polymer. This invention simultaneously introduces magnetite magnetic nanoparticles and simultaneously nucleates and grows the microsphere's basic nucleus, modifying it with multilayer carboxyl functional groups. For example, in the first step, all components are added and mixed uniformly at the start of the reaction—St, MAA, TMP, KPS, magnetic fluid (containing Fe3O4), modified PDX-HES-IPM, etc., coexist in the same reaction system. As KPS decomposes thermally, it triggers the copolymerization and crosslinking of St and MAA, allowing polymer microspheres to "grow" from scratch. During this growth process, the Fe3O4 nanoparticles in the magnetic fluid are physically trapped and encapsulated within the microspheres by the forming three-dimensional crosslinked polymer network, thus preventing the generation of a large number of blank microspheres without Fe3O4 from the source.

[0082] In summary, this invention provides a simple, easy-to-operate, and controllable method for preparing magnetic microspheres using the modified PDX-HES-IPM polymer. The aim is to overcome the shortcomings of traditional microspheres, such as poor monodispersity, low magnetic content, few surface functional groups, easy wall adhesion, easy agglomeration, high non-specific adsorption, and instability. The modified PDX-HES-IPM polymer introduced during the preparation process enables the magnetic microspheres to oriented at the oil / water interface, effectively enhancing the interfacial affinity between inorganic magnetic particles and organic monomers. This allows more iron oxide particles to be embedded within the polymer microspheres, reducing the generation of blank polymer microspheres from the source. The hydroxyl groups abundant in the modified PDX-HES-IPM framework form a stable hydration layer on the microsphere surface, not only supplementing the density of carboxyl functional groups on the surface of the magnetic microspheres but also inhibiting particle aggregation and adhesion through steric hindrance, avoiding adhesion and agglomeration problems, and endowing the magnetic microspheres with good monodispersity and colloidal stability. Simultaneously, the two-step preparation process, under the action of modified PDX-HES-IPM, forms two to multiple layers of polystyrene magnetic microspheres coated with carboxyl functional groups on the surface of the magnetic microspheres, constructing multiple flexible hydration layers. This improves the aqueous dispersibility of the magnetic microspheres, reduces the non-specific adsorption of biomacromolecules such as proteins by the magnetic microspheres, and thus enhances their anti-interference ability and detection accuracy in complex biological samples. The multilayer carboxyl microspheres (multilayer strongly magnetic carboxyl microspheres and multilayer high carboxyl density microspheres) prepared by this invention, compared with traditional magnetic microspheres, significantly improve the monodispersity and colloidal stability of the microspheres while maintaining good magnetic responsiveness through the synergistic design of modified PDX-HES-IPM and a two-step preparation method. This effectively suppresses reactor wall adhesion and interparticle aggregation, and significantly reduces non-specific adsorption levels. The density of carboxyl functional groups on the surface of the final product is significantly improved, exhibiting good application reliability and batch-to-batch consistency, and the overall performance of the microspheres is comprehensively enhanced. Therefore, this invention provides a functionalized, expanded, multilayer carboxyl-coated magnetic nanosphere, effectively overcoming multiple limitations in the preparation process and practical application of this type of commercially available magnetic polymer nanosphere.

[0083] Example 4, Application of Polymers 2: Key Reagents for Preparing Reagent Kits To evaluate the feasibility of using the polymer (modified PDX-HES-IPM) of this invention as an excipient functional additive in chemiluminescence reagents, this invention mainly verified its effects on the stability, non-specific adsorption inhibition effect, and detection sensitivity of different reagents by adding it to three reagent components of magnetic microsphere reagent (M reagent), buffer reagent (R1 reagent), and R2 luminescent label conjugate reagent (R2 reagent) of magnetic microparticle chemiluminescence kits. Meanwhile, parallel controls were set up, with the original reagent without any additional components as the control group and / or with a single raw material component (polydextrose, hydroxyethyl starch, isopropyl myristate) as the additive group. The control group represents the detection results of the original reagent. The ratio of the detection value of the additive group to the detection value of the negative blank sample (N) (signal-to-noise ratio P / N) can be used as the detection result. This is compared with the ratio of the detection value of the control group to the detection value of the same clinical positive sample to the detection value of the negative blank sample (N), and the deviation (ΔP / N) is calculated. This deviation is used as an indicator to measure the "signal enhancement factor". The parallel controls with a single raw material component are used to compare and eliminate the performance interference of the single raw material component, and to accurately locate the unique optimization effect of the polymer of this invention.

[0084] The experimental design and results of this invention systematically evaluating the improvement of the overall performance of the reagent by this polymer compared to the control group and the single raw material component addition group are as follows. The M reagent of the Hepatitis C Virus Antibody Detection Kit (Magnetic Particle Chemiluminescence Method) was selected as the research object. Modified PDX-HES-IPM and its single raw material components (modified polydextrose PDX, hydroxyethyl starch HES, and isopropyl myristate IPM) were added to the M reagent at the following two different concentration levels: 1) Group 1 (low concentration group): modified polydextrose (PDX) 0.25%, hydroxyethyl starch (HES) 0.25%, isopropyl myristate (IPM) 0.25%, modified PDX-HES-IPM 0.25%; 2) Group 2 (high concentration group): modified polydextrose (PDX) 4%, hydroxyethyl starch (HES) 3%, isopropyl myristate (IPM) 0.8%, modified PDX-HES-IPM 4%. Both the additive group (with modified PDX, HES, IPM, and modified PDX-HES-IPM) and the control group (without additives) were prepared under the same buffer system and pH conditions, and were used in the same proportion with R1 and R2 reagents without any additives. Three different test samples were tested in parallel three times using the same fully automated chemiluminescence analyzer. The signal-to-noise ratios (P1 / N, P2 / N, P3 / N) obtained after adding different concentration levels were recorded for the two groups. The relative deviations (ΔP1 / N, ΔP2 / N, ΔP3 / N) between the additive group and the control group without additives were calculated to evaluate the influence of different additives and concentrations on the test results. The test results are shown in Tables 2 and 3 below.

[0085] Table 2 Detection results of reagent M addition group (group 1) ; Table 3. Detection results of reagent M addition group (group 2)

[0086] Tables 2 and 3 show that: First, when a single raw material component or a polymer (modified PDX-HES-IPM) is added to reagent M of the Hepatitis C Virus Antibody Detection Kit (Magnetic Particle Chemiluminescence Method), the corresponding signal-to-noise ratio (P1 / N) and its relative deviation (ΔP / N) between the added group and the control group without the addition are obtained. The results show that there are more or less differences between the detection results of the added group and the control group without the addition, indicating that the additives in the added group have a certain influence on the detection values. Second, the detection signal-to-noise ratio of the group with added single raw material components (such as modified PDX or IPM) decreased compared to the control group without addition (i.e., ΔP was negative). It is speculated that the original reagent represented by the control group lacked effective sealing of the magnetic microsphere surface due to the addition of the polymer of this invention, resulting in a certain degree of non-specific adsorption. The hydrophilicity of the added group, such as modified PDX or IPM, can reduce non-specific adsorption to a certain extent, thereby reducing the "background" signal of the reagent itself. Modified PDX or IPM with single raw material components improved the effect of non-specific adsorption inhibition. However, Tables 2 and 3 show that the effect of single raw material components on improving non-specific adsorption performance is unstable, sometimes ΔP is negative and sometimes ΔP is positive. Third, in the group with the addition of the polymer-modified PDX-HES-IPM of the present invention, the detection signal-to-noise ratio (P / N) is not only significantly higher than that of the control group, but also significantly higher than that of the group with the addition of a single raw material component. Therefore, the relative deviation (ΔP / N) of the detection results of the group with the addition of modified PDX-HES-IPM is significantly higher than that of the group with the addition of a single raw material component. It is speculated that this may be because the amphiphilic segments on the modified PDX-HES-IPM form a more dense and stable hydration layer on the surface of the magnetic microspheres in reagent M under the synergistic effect of the amphiphilic segments. Therefore, it exhibits a stronger resistance to non-specific adsorption during the detection process. By reducing the background signal of the original reagent itself, the detection signal enhancement factor of the original reagent control group is increased. The larger the ΔP / N value, the higher the signal enhancement factor. Thus, by reducing the background signal, the detection sensitivity is improved, which is more conducive to clearly distinguishing between negative and positive results. Fourth, regarding concentration dependence, the average relative deviation (ΔP) of the detection results of the low-concentration addition group (Group 1) was greater than that of the high-concentration group (Group 2). However, the estimated signal enhancement factor (P / N value) of Group 1 was greater than that of Group 2. That is, the detection results of the high-concentration group (Group 2) were more consistent. However, the higher the signal enhancement factor and the higher the sensitivity of the low-concentration group (Group 1), it is speculated that the addition of polymer is relatively more effective. However, there is an optimal concentration range for its addition, which needs further optimization and verification.

[0087] Based on the above analysis of Tables 2 and 3, it can be seen that: (1) the addition group has an impact on the relative deviation (ΔP) of the detection results; (2) the addition group of single raw material component has an impact on non-specific adsorption, and the results are unstable; (3) the inhibitory effect on non-specific adsorption: modified PDX-HES-IPM is better than single raw material component, and significantly enhances the signal enhancement factor (P / N) and sensitivity by reducing the background signal; (4) the addition concentration of polymer can be further optimized and adjusted.

[0088] To systematically evaluate the impact of self-developed polymer-modified PDX-HES-IPM on the performance of core components of a magnetic microparticle chemiluminescence immunoassay system, three key reagents—R1, R2, and M—from a human immunodeficiency virus antigen-antibody detection kit (magnetic microparticle chemiluminescence method) were selected as research subjects. Modified PDX-HES-IPM was added to R1, R2, and M reagents at two parallel levels (low concentration, 0.5%) and high concentration, 5%, respectively, to examine the differences in their effects on the three key reagent components. This provides a basis for the applicability of the polymer in luminescent reagent formulations and the optimization of its addition concentration. The three reagents (R1, R2, and M) containing different concentrations of polymer were used in combination with other R2, M, and R1 reagents without added polymers. A control group (i.e., the original reagents) without added polymers was also set up. All reagents were prepared under the same buffer system and pH conditions. The added M reagent, R1 reagent, and R2 reagent were combined with other corresponding reagent components without added polymers (e.g., M reagent with added polymer was paired with R1 and R2 reagents without added polymers; R1 reagent with added polymer was paired with R2 and M reagents without added polymers; R2 reagent with added polymer was paired with R1 and M reagents without added polymers) to form a complete detection system, and the three human immunodeficiency virus antibody-positive test samples (P1, P2, P3) were tested respectively. Triple replicates (n=3) were performed using the same fully automated chemiluminescence immunoassay analyzer. The chemiluminescence signal intensity (RLU) obtained by each detection system for each sample was recorded. The relative deviation of the enhancement factor (i.e., signal enhancement factor: ΔP1 / N, ΔP2 / N, ΔP3 / N) of each added detection system relative to the control group (i.e., the original reagent system without added polymer) was calculated to evaluate the effect of adding high and low concentrations of modified PDX-HES-IPM on the detection signal intensity and signal-to-noise ratio. The detection results are shown in Table 4 (0.5% added group) and Table 5 (5% added group).

[0089] Table 4. Detection results of adding 0.5% polymer to the three types of reagents. ; Table 5. Detection results of reagents containing 5% polymer in three types.

[0090] As shown in Tables 4 and 5, adding 0.5% to 5% polymer (modified PDX-HES-IPM) to the three key reagents of the Human Immunodeficiency Virus Antigen Antibody Detection Kit (Magnetic Particle Chemiluminescence Method) increases the signal enhancement factor (ΔP1 / N, ΔP2 / N, ΔP3 / N) by 7%-72% compared to the control group (i.e., the original reagent system without polymer) by reducing the background.

[0091] The M reagent in magnetic microparticle chemiluminescence assay uses bare magnetic microspheres as a solid-phase substrate. These microspheres are placed in a specialized magnetic microsphere-coated buffer solution. Under specific pH, temperature, and activation reaction conditions, targeted specific antigens or antibodies are covalently coupled to the surface of the magnetic microspheres. After blocking and multi-step washing to remove unbound free ligands and byproducts, the functionalized immunomagnetic beads are redispersed in a specialized magnetic bead storage buffer solution and adjusted to the specified working concentration to obtain the final reagent. The formulation of the magnetic microsphere-coated buffer solution directly determines the coupling efficiency, coupling amount, and directional binding rate of antibodies on the surface of the magnetic microspheres, ultimately directly affecting the non-specific adsorption level and detection sensitivity of the M reagent.

[0092] Example 5, Application of Polymers 3: Preparation of Upstream Reagents (e.g., Coating Buffer Solutions) To systematically evaluate the application effect of the polymer-modified PDX-HES-IPM of the present invention in the magnetic microsphere coating buffer solution upstream of the magnetic microparticle chemiluminescence immunoassay system, it was used as a surfactant and compared with the commonly used Tween-20. Single raw material components (modified polydextrose PDX, hydroxyethyl starch HES, and isopropyl myristate IPM) were set as parallel controls to clarify the functional advantages of the polymer of the present invention as a surfactant / blocking agent in the coating preparation of reagent M. The verification experiment design is as follows.

[0093] The magnetic microsphere coating buffer (CB) in the M reagent process of the Human Immunodeficiency Virus Antigen-Antibody Detection Kit (Magnetic Microparticle Chemiluminescence Assay) was selected as the research object. 0.01% Tween-20, 0.01% modified polydextrose (PDX), 0.01% hydroxyethyl starch (HES), 0.01% high-purity isopropyl myristate (IPM, purity ≥99%), and 0.01% of the polymer of this invention (modified PDX-HES-IPM) were added in parallel to the magnetic microsphere coating buffer (CB). All the different additives were prepared under the same coating buffer system and pH conditions, and the same magnetic microsphere coating and blocking methods were used, including the same concentration of the same batch of magnetic microspheres and the same concentration of the coated antigen / antibody (e.g., simultaneously including HIV-1 / 2 recombinant antigen and anti-HIV). Using the same coating and blocking processes, including p24 monoclonal antibody, to ensure that the only variable is the type of additive, the antigen and antibody were coupled onto magnetic microspheres in a coating buffer (CB) containing different additives. The M reagent was then prepared using the same washing and resuspension process. Six human immunodeficiency virus antibody-positive samples (P1-P6) and negative control samples were uniformly tested using the same fully automated chemiluminescence immunoassay analyzer. Each sample was tested three times (n=3) using a detection system corresponding to different additives. The chemiluminescence signal intensity (RLU) obtained by each detection system for each sample was recorded, and the signal-to-noise ratio (P / N) of each group was calculated, as well as the difference between the single raw material component and the polymer compared to the control group (i.e., 0.01% additive). The relative deviations of the boost factor (i.e., signal boost factors: ΔP1 / N, ΔP2 / N, ΔP3 / N, ΔP4 / N, ΔP5 / N, ΔP6 / N) of the original reagent system of Tween-20 were observed. At the same time, the suspension state and wall adsorption of the coated magnetic microspheres during storage and use were observed to evaluate the effect of the single raw material component and the polymer of the present invention on the boost factor and storage stability of the reagent detection signal after applying the magnetic microsphere coating buffer solution (CB). The results of RLU, P / N, and ΔP / N are shown in Table 6 below.

[0094] Table 6. Detection results of magnetic microsphere-coated buffer solutions with 0.01% different additives.

[0095] As shown in Table 6: First, adding any single raw material component or a polymer (modified PDX-HES-IPM) to the magnetic microsphere-coated buffer solution (CB) can improve the relative deviation (ΔP / N) of the P / N value relative to the original reagent (with Tween-20 added) to varying degrees. That is, the signal enhancement factor represented by ΔP / N ranges from 13% to 101%. This significant difference in enhancement comes from the additives in the magnetic microsphere-coated buffer solution (CB), and the beneficial effect is to reduce the non-specific adsorption of magnetic microspheres in the M reagent prepared by it. Second, the enhancement effect corresponding to the addition of polymer is significantly better than that of any single raw material component (modified PDX, HES, IPM), with an average signal enhancement factor (ΔP / N) of 79.46%. Third, the addition of polymer can also significantly reduce the mean RLU value (1554) of negative samples, which is the lowest, that is, significantly reduce the background signal of detection. Fourth, when magnetic microspheres were coated with a single raw material component using a magnetic microsphere coating buffer solution (CB), varying degrees of floating and adhering abnormalities were observed during the magnetic separation and cleaning stage of the coating reaction. These abnormalities affected the final recovery rate and batch consistency of the magnetic microspheres. However, no floating phenomenon was observed during the coating preparation of magnetic microspheres with the addition of modified PDX-HES-IPM. Furthermore, the magnetic microspheres exhibited uniform suspension, excellent dispersion, and high recovery rate. This indicates that the addition of modified PDX-HES-IPM completely eliminated the floating abnormality of the coated magnetic microspheres. It is speculated that modified PDX-HES-IPM does not simply function as a surfactant like Tween-20, but rather constructs a uniform and stable hydration protective layer on the surface of the magnetic beads through its synergistic effect of hydrophilic and hydrophobic properties. This allows for multiple and unique performance advantages, including inhibiting non-specific adsorption, improving detection sensitivity, and enhancing the stability of the coating process, even at low dosages.

[0096] In summary, the polymer (modified PDX-HES-IPM) of this invention exhibits multiple functional advantages in magnetic microsphere coating buffer solution at a low concentration of 0.01%: it can act as an effective surfactant in the coating buffer, significantly reducing non-specific adsorption of magnetic microspheres and improving the signal-to-noise ratio; it can also improve the colloidal stability of magnetic microspheres and eliminate floating wall phenomenon. The overall performance of modified PDX-HES-IPM in magnetic microsphere coating buffer solution (CB) is significantly better than that of conventional Tween-20 and any single raw material component, suggesting that this polymer has good application prospects in the coating process of magnetic microspheres.

[0097] Example 6, Application of Polymers 4: Evaluation of Reagent Kit Performance To evaluate the effect of adding the modified PDX-HES-IPM polymer (modified PDX-HES-IPM) to a chemiluminescence detection system and its influence on the overall performance of the kit, the Heart-type Fatty Acid Binding Protein Assay Kit (Magnetic Microparticle Chemiluminescence Method) was used as the research object. This kit is used for the quantitative detection of heart-type fatty acid binding protein (H-FABP) in human serum and plasma. Referring to the application schemes of Examples 4 and 5, the experimental group designed the following three addition methods: 1) Kit 1: Modified PDX-HES-IPM was added only to reagent M (magnetic microsphere suspension); 2) Kit 2: Modified PDX-HES-IPM was added to reagents R1, R2, and M simultaneously; 3) Kit 3: Modified PDX-HES-IPM was added only to the magnetic microsphere coating buffer during the preparation of reagent M. In the buffer (CB), modified PDX-HES-IPM was introduced into kit 3 via a coating coupling process. Reagent M was a magnetic microsphere suspension coated with H-FABP-specific monoclonal antibody (mouse-derived), and reagent R2 was an acridinium ester-labeled H-FABP-specific monoclonal antibody (mouse-derived) solution. A centroid fatty acid-binding protein assay kit (magnetic microparticle chemiluminescence method) without modified PDX-HES-IPM was used as the control group. The basal buffer system, pH value, and antibody working concentration of all reagents in the experimental groups were kept consistent with the original kit in the control group to minimize interference from irrelevant variables. The system performance of the four kits (control group + 3 experimental groups) was evaluated, and the evaluation indicators included blank limit (or blank value), linear range, precision, and stability.

[0098] Blank value determination and evaluation: The test was performed according to the standard operating procedure recommended by the fully automated chemiluminescence analyzer. 20 μL of the test sample and 100 μL of reagent M were added to the reaction tube sequentially, and the tubes were incubated at 37℃ for 15 min, followed by magnetic separation and washing twice. Then, 100 μL of reagent R2 was added, and the tubes were incubated at 37℃ for 10 min, followed by magnetic separation and washing four times. Finally, 100 μL of pre-excitation solution and 100 μL of excitation solution were added sequentially, and the chemiluminescence signal intensity was measured. The test sample was the same negative calibrator (N,H-FABP concentration of 0 ng / mL). The test sample was measured 20 times (n=20), and the coefficient of variation (CV) of each group of test results was calculated using the formula: CV = (standard deviation ÷ mean) × 100%. The test results are shown in Table 7.

[0099] Table 7. Reagent Kit Performance Evaluation: Blank Value

[0100] As shown in Table 7, the test results indicate that, for the same negative calibrator as the test sample, under the same testing conditions, the blank values ​​obtained by the three kits in the experimental group were all lower than those in the control group. Furthermore, the coefficients of variation (CV) of kits 2 and 3 were both below 8%, which is significantly better than the industry-standard acceptable threshold of CV ≤ 10% for blank values ​​of clinical myocardial biomarkers chemiluminescence kits. In addition, the coefficient of variation of kit 2 (modified PDX-HES-IPM added to reagents R1, R2 and M simultaneously) was 6.25%, while the coefficient of variation (CV% = 4.11%) of kit 3 (modified PDX-HES-IPM added only to magnetic microsphere coating buffer) was the lowest and best performing. The above results indicate that the addition of modified PDX-HES-IPM can effectively reduce the background signal (blank value) of the kit for detecting blank negative calibrators, thereby improving the detection precision. Among them, the effects of adding it to the magnetic microsphere coating buffer (kit 3) and adding it to the three key reagents R1 / R2 / M (kit 2) during the preparation of reagent M are the most significant. This confirms that the polymer of the present invention can construct a uniform hydration steric hindrance layer in the reaction system through different introduction pathways, which can significantly suppress the background signal fluctuation caused by non-specific adsorption. In particular, it can effectively improve the repeatability and stability of the detection results by improving the hydration properties of the magnetic microsphere surface, providing a reliable performance basis for the accurate determination of low-concentration positive critical samples of myocardial marker (H-FABP).

[0101] Linearity evaluation: To evaluate the effect of adding the polymer (modified PDX-HES-IPM) to the H-FABP assay kit on the linear response performance of the detection system, based on the blank value determination results, kit 2 (added to reagents R1, R2, and M simultaneously) and kit 3 (added only to the magnetic microsphere coating buffer CB in the preparation process of reagent M) were used as the research objects, and the original H-FABP assay kit (magnetic microparticle chemiluminescence method) without the addition of modified PDX-HES-IPM was used as the control group. The focus was on comparing the differences in linear correlation among the three kits.

[0102] The detection was performed according to the standard operating procedure recommended by the fully automated chemiluminescence analyzer: 20 μL of the test sample and 100 μL of reagent M were added to the reaction tube sequentially, and the tubes were incubated at 37℃ for 15 min, followed by magnetic separation and washing twice; 100 μL of reagent R2 was added, and the tubes were incubated at 37℃ for 10 min, followed by magnetic separation and washing four times; 100 μL of pre-excitation solution and 100 μL of excitation solution were added sequentially, and the chemiluminescence signal intensity was detected. The test samples were negative calibrators (N, H-FABP concentration of 0 ng / mL) and a series of H-FABP calibrators with concentrations ranging from 0.1 to 160 ng / mL. The series concentrations of the test samples were 0 ng / mL, 0.8 ng / mL, 1.25 ng / mL, 5 ng / mL, 10 ng / mL, 20 ng / mL, 40 ng / mL, 80 ng / mL, and 160 ng / mL. The above three kits were used to perform parallel detections on the test samples of the above series of concentrations. Linear regression analysis was performed with the theoretical concentration of H-FABP as the abscissa (X) and the measured chemiluminescence signal intensity as the ordinate (Y) to calculate the linear correlation coefficient (r) corresponding to the detection results of the three kits. The results are shown in Table 8 below.

[0103] Table 8. Reagent Kit Performance Evaluation: Linearity

[0104] Table 8 shows the linearity results: within the linear detection range of 0.08–160 ng / mL, both kits 2 and 3 tested all series of concentration calibrators, and the results all showed a high linear positive correlation with the theoretical concentration, with linear correlation coefficients r ≥ 0.990, fully meeting the general linear performance standards for myocardial biomarker magnetic microparticle chemiluminescence kits. Compared with the control group, there was no significant difference in the linear correlation coefficient r between kits 2 and 3. These linear results indicate that the addition of modified PDX-HES-IPM (whether added simultaneously to reagents R1 / R2 / M or only to the magnetic microsphere coating buffer during reagent M preparation) does not interfere with the dose-response linearity of the detection system within the target concentration range. Furthermore, it maintains the inherent linear response characteristics of the detection system while improving other performance indicators of the kit (such as reducing blank values ​​and improving precision). In other words, the optimized kit system did not introduce new concentration-dependent interferences or matrix effects, further verifying the compatibility and applicability of modified PDX-HES-IPM as an additive in chemiluminescence detection systems.

[0105] Precision evaluation: To evaluate the effect of adding the polymer (modified PDX-HES-IPM) to the H-FABP detection kit on the precision (reproducibility) of the detection system, based on blank value and linearity verification, kit 2 (polymer added to reagents R1, R2, and M simultaneously) and kit 3 (polymer added to the magnetic microsphere-coated buffer CB in the preparation process of reagent M) were used as the research objects, and the original kit without polymer was used as the control group. The focus was on comparing the precision differences between the two addition methods and the control group.

[0106] The detection was performed according to the standard operating procedure recommended by the fully automated chemiluminescence analyzer: 20 μL of the test sample and 100 μL of reagent M were added to the reaction tube sequentially, incubated at 37℃ for 15 min, and magnetically separated and washed twice; 100 μL of reagent R2 was added, incubated at 37℃ for 10 min, and magnetically separated and washed four times; 100 μL of pre-excitation solution and 100 μL of excitation solution were added sequentially, and the chemiluminescence signal intensity was detected. The test sample was a mixed clinical serum sample, prepared at three concentration levels: low (1.25 ng / mL), medium (20 ng / mL), and high (80 ng / mL). The three reagent kits were used to repeatedly measure the test sample at each concentration level 10 times (n=10), and the coefficient of variation (CV) of the measurement results was calculated using the formula: CV = (standard deviation ÷ mean) × 100%. The detection results are shown in Table 9.

[0107] Table 9. Reagent Kit Performance Evaluation: Precision

[0108] The test results shown in Table 9 indicate that, compared with the control group, the coefficients of variation (CV) of reagent kits 2 and 3 for the low, medium, and high concentration levels were all significantly lower than the industry-standard 10% threshold. This demonstrates a small degree of dispersion among the test results, exhibiting good intra-batch precision and repeatability, and accurately reflecting the true concentration of the samples. Furthermore, the CVs of reagent kits 2, 3, and the control group for the three concentration levels were all less than 5%, achieving a high level of precision. This indicates that the addition of the modified PDX-HES-IPM in this invention reduces background signal without introducing new random variables into the detection system, and therefore does not significantly affect the stability and accuracy of the reagent kit test results. In particular, kits 2 and 3 showed relatively lower coefficients of variation (CV) for detecting low concentration levels of test samples. The CV decreased from 2.54% in the control group to 2.12% and 1.96% in kits 2 and 3, respectively, representing reductions of 16.5% and 22.8%. This indicates that the polymer stabilizes the reagent components and reduces non-specific adsorption, thereby enhancing the reproducibility of the kit detection system in the low concentration range. This reduces the risk of misjudgment and missed judgment that may be caused by errors in detecting critically low-value samples, accurately distinguishing the true H-FABP concentration in clinical serum samples. This fully meets the high-precision detection requirements in the rapid diagnosis of myocardial injury and is of great significance for improving the reliability and accuracy of clinical testing. Therefore, the addition of modified PDX-HES-IPM can be considered as one of the ideal additives for performance optimization of magnetic microparticle chemiluminescence reagent kits.

[0109] Stability evaluation: To evaluate the effect of adding the polymer (modified PDX-HES-IPM) to the H-FABP detection kit on the stability of the reagent, the control group (original kit without addition), kit 2 (with R1, R2 and M reagents added simultaneously) and kit 3 (added only to the magnetic microsphere coating buffer in the preparation process of reagent M) were used as the research objects. However, the stability was mainly examined under different storage conditions and storage time.

[0110] The M reagent (containing magnetic microspheres coated with H-FABP specific monoclonal antibody) from the three kits mentioned above was stored at 4℃ and 37℃, respectively, to focus on the effect of accelerated thermal acceleration on the magnetic microspheres. The storage times were 3 days, 7 days, and 14 days, respectively. Using the initial test results conducted on the same day after the M reagent was prepared (stored at 4℃) as a reference (stability baseline, denoted as 100%), samples were taken at different storage time points and tested according to the precision evaluation method described above and the standard operating procedure recommended by the fully automated chemiluminescence analyzer. The test samples were prepared from mixed clinical serum samples at three concentration levels: low (1.25 ng / mL), medium (20 ng / mL), and high (80 ng / mL). Each concentration level sample was measured three times (n=3) using the three kits mentioned above under different storage conditions. The chemiluminescence signal intensity obtained by the corresponding kits for the test samples after M reagent under different storage conditions was recorded. The signal retention rate of the test results was calculated based on the initial test results. The test results are shown in Table 10 below.

[0111] Table 10 Reagent Kit Performance Evaluation: Stability

[0112] The detection results shown in Table 10 indicate that after 14 days of storage at 37℃, the detection signal retention rates of the control group's M reagent for low, medium, and high concentration levels were 85%, 88%, and 77%, respectively. In contrast, the detection signal retention rates of the M reagents in kits 2 and 3 after 14 days of storage at 37℃ for low, medium, and high concentration levels were 96%, 98% / 99%, and 97%, respectively. All three kits showed a detection signal retention rate greater than 95%, significantly higher than the control group (≥77%), indicating that modified PDX-HES-IPM, whether added directly to the M reagent or to the magnetic microsphere coating buffer during the M reagent preparation process, helps protect the bioactivity of the antibody coated on the surface of the magnetic microspheres in the M reagent and slows down its activity at 37℃. The activity decay under accelerated thermal conditions at ℃ significantly improves the storage and detection stability of reagent M. This is presumably due to the synergistic effect of the amphiphilic polymer (modified PDX-HES-IPM) of this invention, which constructs a stable hydration protective layer on the surface of magnetic beads and forms a hydrophilic protective microenvironment around the biological ligands. This effectively inhibits the aging pathway of antibody molecule thermal denaturation and inactivation and increased non-specific adsorption of magnetic beads, greatly improving the long-term storage stability of reagent M. Compared to storage at 37℃, the stability of reagent M in the three kits is higher when stored at 4℃. Moreover, the stability of reagent M in kits 2 and 3 stored at 4℃ is not significantly different from that stored at 37℃, and both are greater than 97%. It can be seen that adding the modified PDX-HES-IPM of this invention to the magnetic particle chemiluminescence assay kit is beneficial to directly extend the shelf life of the kit at 2~8℃ or even at room temperature, and further improve the stability and precision of kits such as the validation reagent (clinical myocardial marker) of this invention.

[0113] In summary, by evaluating the performance of the modified PDX-HES-IPM in the H-FABP detection kit in terms of blank value, linearity, precision, and stability, the results demonstrate that the addition of modified PDX-HES-IPM to the H-FABP detection kit (whether added simultaneously to reagents R1 / R2 / M or only to reagent M or its coating buffer) effectively reduces the background signal of the reagent detection without affecting the linear response and precision. Furthermore, it improves the long-term stability and accuracy of the reagent. In particular, kit 3 (added only to the coating buffer) achieves a relatively ideal overall performance improvement with the fewest addition sites, making it a more cost-effective and preferred addition method. These performance evaluation results fully verify the applicability of modified PDX-HES-IPM as a multifunctional additive in magnetic microparticle chemiluminescence detection systems and its application potential in optimizing IVD reagent performance.

[0114] This invention provides a polymer, its preparation method, and its application in chemiluminescent reagents. The polymer provided by this invention is a modified PDX-HES-IPM prepared by modifying polydextrose (PDX), hydroxyethyl starch (HES), and isopropyl myristate (IPM). The modified PDX-HES-IPM is demonstrated by FT-IR, UV-Vis, and ESI-MS to be a complex that combines the hydrophilic stability of the PDX polysaccharide backbone, the steric hindrance protection of the HES chain segment, and the hydrophobic ester functional groups on the IPM. Modified PDX-HES-IPM can be used as a dispersant for the expansion preparation of nanomagnetic microspheres with multilayered carboxyl functional groups and strong magnetic properties. It can also be added as an exogenous functional additive to reagents R1, R2, and M in magnetic microparticle chemiluminescence kits. Furthermore, it can be applied to upstream key preparation solutions such as coating buffer solutions. Results show that adding 0.01%-5% modified PDX-HES-IPM significantly suppresses non-specific adsorption during chemiluminescence detection. By constructing a stable hydration steric hindrance layer on the magnetic bead surface, it significantly reduces reagent background signal and improves the signal-to-noise ratio (P / N value) of the kit. Adding it to the upstream coating buffer solution can also eliminate the floating wall phenomenon during the magnetic microsphere coating process, thereby further reducing the blank value and coefficient of variation (CV≤8%) of chemiluminescence detection, improving the storage stability of the kit, and without affecting the linearity and precision of the kit. This significantly reduces the risk of false negatives in clinical detection of low-value samples and is widely applicable to various magnetic microparticle chemiluminescence detection scenarios.

[0115] Specific embodiments of the present invention have been described in detail to facilitate understanding by those skilled in the art. However, based on all the disclosed descriptions, various modifications or substitutions can be made to those details, and all such changes are within the scope of protection of the present invention. The full scope of the present invention is given by the appended claims and any equivalents thereof.

Claims

1. A polymer-modified PDX-HES-IPM, characterized in that: It is a complex with a copolymer network structure prepared from modified polydextrose, hydroxyethyl starch and isopropyl myristate as raw materials.

2. The polymer-modified PDX-HES-IPM according to claim 1, characterized in that: The hydrophobic ester group of the isopropyl myristate segment is extended into the polyethylene glycol structure formed by ring opening of ethylene oxide.

3. The polymer-modified PDX-HES-IPM according to claim 1, characterized in that: The polysaccharide backbone is formed by modified polydextrose with hydrophilic stability and hydroxyethyl starch, and hydrophobic IPM ester functional groups.

4. A method for preparing polymer-modified PDX-HES-IPM, characterized in that: Includes the following steps: 1) In the presence of propylene glycol and an alkaline catalyst, modified polydextrose and hydroxyethyl starch were subjected to an etherification and crosslinking reaction under heating conditions to obtain modified PDX-HES with a copolymer network structure; 2) After completely dissolving isopropyl myristate in a solvent, it is transferred to the modified PDX-HES obtained in step 1). Under inert gas protection and heating conditions, isopropyl myristate is added by dropwise ethylene oxide polyethylene glycol chain extension to obtain ternary polymer main chain modified PDX-HES-IPM. 3) The main chain modified PDX-HES-IPM obtained in step 2) is neutralized with acetic acid, purified, and dehydrated to obtain the target polymer modified PDX-HES-IPM.

5. The preparation method of polymer-modified PDX-HES-IPM according to claim 4, characterized in that: The mass ratio of the modified polydextrose, hydroxyethyl starch and isopropyl myristate is 10:10:

1.

6. A type of magnetic nanosphere, characterized in that: The nanomagnetic microspheres are prepared by using the polymer-modified PDX-HES-IPM according to any one of claims 1 to 3, wherein the surface of the nanomagnetic microspheres is coated with multiple carboxyl functional groups and / or more Fe3O4 nanoparticles are embedded.

7. A magnetic microparticle chemiluminescence detection kit, characterized in that: The kit includes reagent R1, reagent R2 and reagent M, wherein at least one reagent contains the polymer-modified PDX-HES-IPM as described in any one of claims 1 to 3.

8. The magnetic particle chemiluminescence detection kit according to claim 6, characterized in that: The mass concentration of the polymer-modified PDX-HES-IPM added is 0.01% to 5%.

9. The magnetic particle chemiluminescence detection kit according to claim 6, characterized in that: The M reagent is a magnetic microsphere suspension coated with specific antibodies and / or antigens, and the coating buffer in the preparation process of the magnetic microsphere suspension contains the polymer-modified PDX-HES-IPM as described in any one of claims 1 to 3.

10. The application of the polymer-modified PDX-HES-IPM according to any one of claims 1-3, the preparation method of the polymer-modified PDX-HES-IPM according to any one of claims 4-5, the magnetic nanospheres according to claim 6, and the magnetic microparticle chemiluminescence detection kit according to any one of claims 7-9 in the preparation of in vitro diagnostic reagents, wherein the application does not include methods for the diagnosis and treatment of diseases.